Entropy Technologies LP Makes New Investment in Agilent Technologies, Inc. (NYSE:A)

Entropy Technologies LP purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 20,975 shares of the medical research company's stock, valued at approximately $3,114,000.

A number of other institutional investors have also recently made changes to their positions in A. Western Pacific Wealth Management LP raised its position in Agilent Technologies by 18.9% in the first quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company's stock worth $64,000 after acquiring an additional 70 shares during the period. Menard Financial Group LLC raised its position in Agilent Technologies by 1.6% in the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company's stock worth $628,000 after acquiring an additional 77 shares during the period. McAdam LLC raised its position in Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company's stock worth $376,000 after acquiring an additional 77 shares during the period. Global Retirement Partners LLC raised its position in Agilent Technologies by 3.2% in the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company's stock worth $382,000 after acquiring an additional 79 shares during the period. Finally, Rovin Capital UT ADV raised its position in Agilent Technologies by 1.6% in the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock worth $750,000 after acquiring an additional 81 shares during the period.

Agilent Technologies Stock Down 0.1 %

Shares of Agilent Technologies stock traded down $0.20 on Tuesday, reaching $133.66. The stock had a trading volume of 1,490,442 shares, compared to its average volume of 1,704,506. The company has a 50 day moving average price of $139.27 and a 200 day moving average price of $138.19. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 1 year low of $106.96 and a 1 year high of $155.35. The stock has a market capitalization of $38.40 billion, a P/E ratio of 27.77, a P/E/G ratio of 6.01 and a beta of 1.07.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies's revenue was down 5.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.43 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.71%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 19.50%.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. Stifel Nicolaus restated a "buy" rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Barclays lifted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an "underweight" rating in a research note on Tuesday, October 15th. UBS Group lifted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a "neutral" rating in a research note on Thursday, August 22nd. Citigroup lifted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a "buy" rating in a research note on Thursday, August 22nd. Finally, Wells Fargo & Company began coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and an average price target of $144.36.

Insider Activity

In other news, SVP Dominique Grau sold 9,990 shares of the company's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company's stock, valued at $5,801,595. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business's stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at $3,497,110. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company's stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock valued at $1,739,510 in the last ninety days.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.